Prosperity Consulting Group, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1910398 OWINGS MILLS, MD

Position in VRTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$485,801

+$236,632 QoQ

Shares Held

978

+75.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,092

of 1,746 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Prosperity Consulting Group, LLC holds $1,287,184 across 4 Biotechnology names. VRTX ranks #1 (37.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	978	$485,801
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,152	$346,786
3	REGN	Regeneron Pharmaceuticals, Inc.	402	$250,663
4	INCY	Incyte Corp	1,799	$203,934

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$485,801	978	+75.3%	Shares	Sole	2026-08-13
2026-03-31	$249,169	558	-59.9%	Shares	Sole	2026-05-05
2025-12-31	$631,530	1,393	-54.3%	Shares	Sole	2026-02-17
2025-09-30	$1,193,718	3,048	+3.3%	Shares	Sole	2025-11-14
2025-06-30	$1,313,340	2,950	-1.8%	Shares	Sole	2025-08-05
2025-03-31	$1,456,399	3,004	+2.9%	Shares	Sole	2025-05-07
2024-12-31	$1,175,481	2,919	-18.5%	Shares	Sole	2025-02-14
2024-09-30	$1,664,986	3,580	+301.3%	Shares	Sole	2024-10-15
2024-06-30	$418,098	892	—	Shares	Sole	2024-08-08
No filing history on record for this holder in this stock.